Logo image of TM

TOYOTA MOTOR CORP -SPON ADR (TM) Stock Fundamental Analysis

NYSE:TM - New York Stock Exchange, Inc. - US8923313071 - ADR

186.93  +6.15 (+3.4%)

After market: 186.93 0 (0%)

Fundamental Rating

6

TM gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 42 industry peers in the Automobiles industry. While TM has a great profitability rating, there are quite some concerns on its financial health. TM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

TM had positive earnings in the past year.
TM had a positive operating cash flow in the past year.
In the past 5 years TM has always been profitable.
TM had a positive operating cash flow in each of the past 5 years.
TM Yearly Net Income VS EBIT VS OCF VS FCFTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2T 4T

1.2 Ratios

TM's Return On Assets of 4.78% is amongst the best of the industry. TM outperforms 87.50% of its industry peers.
TM has a Return On Equity of 12.40%. This is amongst the best in the industry. TM outperforms 82.50% of its industry peers.
With an excellent Return On Invested Capital value of 6.05%, TM belongs to the best of the industry, outperforming 87.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for TM is below the industry average of 9.39%.
The 3 year average ROIC (4.46%) for TM is below the current ROIC(6.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.78%
ROE 12.4%
ROIC 6.05%
ROA(3y)4.33%
ROA(5y)4.08%
ROE(3y)11.32%
ROE(5y)10.69%
ROIC(3y)4.46%
ROIC(5y)4.18%
TM Yearly ROA, ROE, ROICTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10

1.3 Margins

TM's Profit Margin of 9.19% is amongst the best of the industry. TM outperforms 87.50% of its industry peers.
In the last couple of years the Profit Margin of TM has grown nicely.
Looking at the Operating Margin, with a value of 11.33%, TM belongs to the top of the industry, outperforming 92.50% of the companies in the same industry.
In the last couple of years the Operating Margin of TM has grown nicely.
TM has a better Gross Margin (21.13%) than 75.00% of its industry peers.
In the last couple of years the Gross Margin of TM has grown nicely.
Industry RankSector Rank
OM 11.33%
PM (TTM) 9.19%
GM 21.13%
OM growth 3Y13.7%
OM growth 5Y7.77%
PM growth 3Y9.95%
PM growth 5Y12.15%
GM growth 3Y5.37%
GM growth 5Y2.9%
TM Yearly Profit, Operating, Gross MarginsTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), TM is destroying value.
Compared to 1 year ago, TM has less shares outstanding
Compared to 5 years ago, TM has less shares outstanding
Compared to 1 year ago, TM has a worse debt to assets ratio.
TM Yearly Shares OutstandingTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
TM Yearly Total Debt VS Total AssetsTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20T 40T 60T 80T

2.2 Solvency

TM has an Altman-Z score of 1.73. This is a bad value and indicates that TM is not financially healthy and even has some risk of bankruptcy.
TM has a Altman-Z score of 1.73. This is in the better half of the industry: TM outperforms 75.00% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that TM is somewhat dependend on debt financing.
TM's Debt to Equity ratio of 0.63 is on the low side compared to the rest of the industry. TM is outperformed by 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 1.73
ROIC/WACC0.76
WACC7.94%
TM Yearly LT Debt VS Equity VS FCFTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10T 20T 30T

2.3 Liquidity

A Current Ratio of 1.23 indicates that TM should not have too much problems paying its short term obligations.
The Current ratio of TM (1.23) is comparable to the rest of the industry.
TM has a Quick Ratio of 1.07. This is a normal value and indicates that TM is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.07, TM is in line with its industry, outperforming 57.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.07
TM Yearly Current Assets VS Current LiabilitesTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10T 20T 30T

5

3. Growth

3.1 Past

TM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.05%, which is quite good.
TM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.98% yearly.
The Revenue has grown by 12.00% in the past year. This is quite good.
TM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.33% yearly.
EPS 1Y (TTM)11.05%
EPS 3Y31.58%
EPS 5Y22.98%
EPS Q2Q%-54.34%
Revenue 1Y (TTM)12%
Revenue growth 3Y18.33%
Revenue growth 5Y8.33%
Sales Q2Q%0.09%

3.2 Future

TM is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.01% yearly.
The Revenue is expected to grow by 4.24% on average over the next years.
EPS Next Y-10.52%
EPS Next 2Y-4.53%
EPS Next 3Y-2.01%
EPS Next 5YN/A
Revenue Next Year5.71%
Revenue Next 2Y4.65%
Revenue Next 3Y4.24%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TM Yearly Revenue VS EstimatesTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10T 20T 30T 40T 50T
TM Yearly EPS VS EstimatesTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1K 2K 3K

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.06, the valuation of TM can be described as very reasonable.
Compared to the rest of the industry, the Price/Earnings ratio of TM indicates a rather cheap valuation: TM is cheaper than 85.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.29. TM is valued rather cheaply when compared to this.
Based on the Price/Forward Earnings ratio of 8.60, the valuation of TM can be described as reasonable.
87.50% of the companies in the same industry are more expensive than TM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of TM to the average of the S&P500 Index (24.44), we can say TM is valued rather cheaply.
Industry RankSector Rank
PE 9.06
Fwd PE 8.6
TM Price Earnings VS Forward Price EarningsTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TM is valued cheaper than 87.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.12
TM Per share dataTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

TM has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as TM's earnings are expected to decrease with -2.01% in the coming years.
PEG (NY)N/A
PEG (5Y)0.39
EPS Next 2Y-4.53%
EPS Next 3Y-2.01%

6

5. Dividend

5.1 Amount

TM has a Yearly Dividend Yield of 3.17%.
Compared to an average industry Dividend Yield of 3.90, TM pays a better dividend. On top of this TM pays more dividend than 92.50% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.28, TM pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.17%

5.2 History

The dividend of TM is nicely growing with an annual growth rate of 7.71%!
TM has paid a dividend for at least 10 years, which is a reliable track record.
TM has decreased its dividend recently.
Dividend Growth(5Y)7.71%
Div Incr Years1
Div Non Decr Years1
TM Yearly Dividends per shareTM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200

5.3 Sustainability

23.74% of the earnings are spent on dividend by TM. This is a low number and sustainable payout ratio.
DP23.74%
EPS Next 2Y-4.53%
EPS Next 3Y-2.01%
TM Yearly Income VS Free CF VS DividendTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2T 4T
TM Dividend Payout.TM Dividend Payout, showing the Payout Ratio.TM Dividend Payout.PayoutRetained Earnings

TOYOTA MOTOR CORP -SPON ADR

NYSE:TM (1/21/2025, 6:40:00 PM)

After market: 186.93 0 (0%)

186.93

+6.15 (+3.4%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-06 2024-11-06/dmh
Earnings (Next)02-05 2025-02-05/amc
Inst Owners24.94%
Inst Owner Change-1.84%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap245.10B
Analysts78.52
Price Target184.62 (-1.24%)
Short Float %0.1%
Short Ratio2.15
Dividend
Industry RankSector Rank
Dividend Yield 3.17%
Yearly Dividend65.1
Dividend Growth(5Y)7.71%
DP23.74%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-28 2025-03-28 (50)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.92%
Min EPS beat(2)-41.93%
Max EPS beat(2)8.1%
EPS beat(4)3
Avg EPS beat(4)1.05%
Min EPS beat(4)-41.93%
Max EPS beat(4)22.06%
EPS beat(8)6
Avg EPS beat(8)13.66%
EPS beat(12)9
Avg EPS beat(12)9.15%
EPS beat(16)13
Avg EPS beat(16)16.4%
Revenue beat(2)0
Avg Revenue beat(2)-0.4%
Min Revenue beat(2)-0.66%
Max Revenue beat(2)-0.14%
Revenue beat(4)2
Avg Revenue beat(4)2.9%
Min Revenue beat(4)-0.66%
Max Revenue beat(4)7.45%
Revenue beat(8)6
Avg Revenue beat(8)4.05%
Revenue beat(12)10
Avg Revenue beat(12)3.79%
Revenue beat(16)14
Avg Revenue beat(16)4.1%
PT rev (1m)3.44%
PT rev (3m)-5.14%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-7.53%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.76%
Revenue NY rev (1m)-0.57%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 9.06
Fwd PE 8.6
P/S 0.83
P/FCF N/A
P/OCF 10.24
P/B 1.12
P/tB 1.16
EV/EBITDA 7.12
EPS(TTM)20.64
EY11.04%
EPS(NY)21.73
Fwd EY11.63%
FCF(TTM)-9.46
FCFYN/A
OCF(TTM)18.26
OCFY9.77%
SpS226.22
BVpS167.57
TBVpS161.16
PEG (NY)N/A
PEG (5Y)0.39
Profitability
Industry RankSector Rank
ROA 4.78%
ROE 12.4%
ROCE 8.59%
ROIC 6.05%
ROICexc 7.85%
ROICexgc 8.08%
OM 11.33%
PM (TTM) 9.19%
GM 21.13%
FCFM N/A
ROA(3y)4.33%
ROA(5y)4.08%
ROE(3y)11.32%
ROE(5y)10.69%
ROIC(3y)4.46%
ROIC(5y)4.18%
ROICexc(3y)5.5%
ROICexc(5y)5.13%
ROICexgc(3y)13.43%
ROICexgc(5y)16.85%
ROCE(3y)6.91%
ROCE(5y)6.56%
ROICexcg growth 3Y-42.54%
ROICexcg growth 5Y7.18%
ROICexc growth 3Y18.6%
ROICexc growth 5Y6.62%
OM growth 3Y13.7%
OM growth 5Y7.77%
PM growth 3Y9.95%
PM growth 5Y12.15%
GM growth 3Y5.37%
GM growth 5Y2.9%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA 2.9
Cap/Depr 259.06%
Cap/Sales 12.26%
Interest Coverage 3.72
Cash Conversion 50.26%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.07
Altman-Z 1.73
F-Score7
WACC7.94%
ROIC/WACC0.76
Cap/Depr(3y)211.26%
Cap/Depr(5y)219.56%
Cap/Sales(3y)11.13%
Cap/Sales(5y)11.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.05%
EPS 3Y31.58%
EPS 5Y22.98%
EPS Q2Q%-54.34%
EPS Next Y-10.52%
EPS Next 2Y-4.53%
EPS Next 3Y-2.01%
EPS Next 5YN/A
Revenue 1Y (TTM)12%
Revenue growth 3Y18.33%
Revenue growth 5Y8.33%
Sales Q2Q%0.09%
Revenue Next Year5.71%
Revenue Next 2Y4.65%
Revenue Next 3Y4.24%
Revenue Next 5YN/A
EBIT growth 1Y26.91%
EBIT growth 3Y34.55%
EBIT growth 5Y16.75%
EBIT Next Year19620%
EBIT Next 3Y488.53%
EBIT Next 5YN/A
FCF growth 1Y-9655.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.75%
OCF growth 3Y15.54%
OCF growth 5Y2.23%